%A Chen Luojun, Li Na, Tian Jingyuan, Xu Bin, Song Qibin %T Analysis of prognosis factors in nonfunctional pancreatic neuroendocrine carcinoma %0 Journal Article %D 2018 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673-422X.2018.12.004 %P 721-726 %V 45 %N 12 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_10554.shtml} %8 2018-12-08 %X ObjectiveTo investigate the prognosis factors of patients with nonfunctional pancreatic neuroendocrine carcinoma (NFPanNEC). MethodsThe patients with NFPanNEC confirmed by pathology from 2004 to 2015 were collected from the Surveillance, Epidemiology, and End Results (SEER) database of the American National Cancer Institute. The MatchIt package in the R software was used to perform propensitymatching analysis of surgery, radiotherapy and chemotherapy. The KaplanMeier method was used to calculate the cumulative survival rate, and the significant difference was evaluated by the logrank test. Then the Cox multivariate regression analysis was applied to evaluate the prognostic factors of NFPanNEC patients. ResultsA total of 2 603 NFPanNEC patients were included in the analysis. Univariate analysis showed that the age of diagnosis (χ2=123.8, P<0.001), gender (χ2=7.3, P=0.007), marital status (χ2=26.7, P<0.001), primary site of tumor (χ2=47.8, P<0.001), degree of tumor differentiation (χ2=628.7, P<0.001), American Joint Committee on Cancer (AJCC) stage (χ2=811.7, P<0.001), T stage (χ2=425.9, P<0.001), N stage (χ2=272.3, P<0.001), M stage (χ2=779.8, P<0.001), surgery (χ2=962.6, P<0.001), chemotherapy (χ2=21.9, P<0.001) were associated with the prognosis of NFPanNEC patients. No correlation was observed between radiotherapy and the prognosis of NFPanNEC patients (χ2=0.1, P=0.750). Multivariate Cox regression analysis showed that older diagnostic age (≥74 years old vs. ≤56 years old, HR=2.20, 95%CI: 1.842.62, P<0.001), male (male vs. female, HR=1.14, 95%CI为1.01~1.29, P=0.035), single or divorced or widowed (single or divorced vs. married, HR=1.26, 95%CI: 1.101.45, P=0.001; widowed vs. married, HR=1.29, 95%CI: 1.041.61, P=0.022), head of pancreas (tail of pancreas vs. head of pancreas, HR=0.85, 95%CI: 0.730.99, P=0.033), poor differentiation (grade Ⅳ vs. grade Ⅰ, HR=3.75, 95%CI: 2.705.20, P<0.001), late AJCC stage (stage Ⅳ vs. stage Ⅰ, HR=5.72, 95%CI: 4.237.73, P<0.001), no surgery treatment (yes vs. no, HR=0.37, 95%CI: 0.300.44, P<0.001) were significant prognostic risk factors for NFPanNEC patients, and chemotherapy was not independent prognostic factor (yes vs. no, HR=1.00, 95%CI: 0.881.13, P=0.958). ConclusionThe older diagnostic age, single or divorced or windowed, head of pancreas, poor differentiation, late AJCC stage and no surgery treatment are significant prognostic risk factors for NFPanNEC patients. Radiotherapy and chemotherapy may not improve the prognosis of NFPanNEC patients.